Tickers

1. Composite Trajectory Verdict

All three financial statements carry roughly equal weight for assessing Loews because its holding company structure spans insurance (balance sheet reserves and capital), midstream (cash flow generation for distributions), and hotels (earnings contribution), with the parent reliant on subsidiary dividends and investment income.

Composite Trajectory: Improving

Overall Assessment: The annual income statement shows consistent improvement with net income attributable to Loews rising 18% to $1,667 million in 2025 from $1,414 million in 2024, driven by higher earnings at CNA Financial ($1,173 million vs $879 million) and Boardwalk Pipelines ($444 million vs $413 million) (10-K 2025, MD&A Results of Operations). Consolidated revenues increased 5.4% to $18,454 million (10-K 2025, Consolidated Statements of Operations). Operating cash flow rebounded to $3,279 million in 2025 from $3,025 million in 2024, though still below the 2023 level of $3,907 million (10-K 2025, Consolidated Statements of Cash Flows). The balance sheet strengthened with shareholders' equity growing 9.5% to $18,686 million and long-term debt declining 5.6% to $8,437 million, even as short-term debt rose due to current maturities (10-K 2025, Consolidated Balance Sheets). The mixed cash flow trajectory (improving year-over-year but below 2023) tempers an otherwise improving picture.

2. Red Flags

• Short-term debt surged to $1,052 million at year-end 2025 from $5 million at year-end 2024, reflecting reclassification of maturing long-term debt (including Boardwalk Pipelines' $600 million notes due December 2024 and CNA's $500 million notes due March 2026) (10-K 2025, Consolidated Balance Sheets; MD&A Liquidity and Capital Resources).
• CNA recorded unfavorable net prior year loss reserve development of $51 million in 2025 versus favorable development of $31 million in 2024, with a $106 million after-tax charge for legacy mass tort abuse reserves in 2025 compared to $62 million in 2024 (10-K 2025, MD&A CNA Financial Other Insurance Operations).
• Loews Hotels & Co recognized a $25 million asset impairment charge in 2025 related to the planned replacement of the Arlington Sheraton Hotel (10-K 2025, MD&A Loews Hotels & Co).
• Consolidated net cash used in investing activities widened to $2,828 million in 2025 from $1,975 million in 2024, primarily due to increased purchases of fixed maturities and limited partnership investments (10-K 2025, Consolidated Statements of Cash Flows).
• Operating cash flow in 2025 ($3,279 million) remained 16% below the 2023 level ($3,907 million) despite year-over-year improvement (10-K 2025, Consolidated Statements of Cash Flows).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Improving

Overall Assessment: Net income attributable to Loews Corporation increased for the second consecutive year, reaching $1,667 million in 2025 versus $1,414 million in 2024 and $1,434 million in 2023 (10-K 2025, Consolidated Statements of Operations). Diluted EPS rose to $7.97 from $6.41 and $6.29 over the same periods (10-K 2025, Consolidated Statements of Operations). The improvement was driven by CNA Financial, where net income attributable to Loews grew 33% to $1,173 million, aided by higher underwriting income and net investment income, partially offset by unfavorable prior year reserve development (10-K 2025, MD&A CNA Financial). Boardwalk Pipelines contributed $444 million, up 7.5% from $413 million, on higher transportation and storage revenues (10-K 2025, MD&A Boardwalk Pipelines). Loews Hotels & Co declined to $31 million from $70 million due to an impairment charge, higher interest expense, and renovation impacts (10-K 2025, MD&A Loews Hotels & Co). Corporate segment earnings fell to $19 million from $52 million on lower parent company investment income (10-K 2025, MD&A Corporate). Consolidated revenues grew steadily: $18,454 million in 2025 vs $17,510 million in 2024 vs $15,901 million in 2023 (10-K 2025, Consolidated Statements of Operations).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Mixed

Overall Assessment: Net cash provided by operating activities increased to $3,279 million in 2025 from $3,025 million in 2024, but remained well below the 2023 level of $3,907 million (10-K 2025, Consolidated Statements of Cash Flows). The year-over-year improvement reflected higher net income and changes in working capital, while the decline from 2023 was driven by increased net claim payments and higher operating expenses at CNA (10-K 2025, MD&A Liquidity and Capital Resources). Net cash used in investing activities expanded to $2,828 million in 2025 from $1,975 million in 2024, mainly due to increased purchases of fixed maturities ($7,118 million vs $6,353 million) and limited partnership investments ($447 million vs $335 million) (10-K 2025, Consolidated Statements of Cash Flows). Net cash used in financing activities narrowed to $513 million from $898 million, as debt issuance ($1,401 million) exceeded repayments ($869 million) and share repurchases rose to $806 million from $608 million (10-K 2025, Consolidated Statements of Cash Flows). Dividends paid to shareholders were stable at $52 million (10-K 2025, Consolidated Statements of Cash Flows).

5. Balance Sheet Assessment

Balance Sheet Trajectory: Improving

Overall Assessment: Total assets grew 5.4% to $86,348 million at December 31, 2025 from $81,943 million a year earlier, driven by higher investment balances ($55,376 million vs $51,130 million) and receivables ($10,983 million vs $10,522 million) (10-K 2025, Consolidated Balance Sheets). Total liabilities increased 4.2% to $66,707 million, with insurance reserves rising 4.8% to $47,682 million (10-K 2025, Consolidated Balance Sheets). Shareholders' equity advanced 9.5% to $18,686 million, lifted by retained earnings growth to $17,377 million from $16,459 million and a reduction in accumulated other comprehensive loss to -$1,067 million from -$1,867 million (10-K 2025, Consolidated Balance Sheets). Long-term debt decreased to $8,437 million from $8,939 million, while short-term debt jumped to $1,052 million from $5 million due to current maturities (10-K 2025, Consolidated Balance Sheets). Noncontrolling interests increased to $955 million from $871 million (10-K 2025, Consolidated Balance Sheets). The debt-to-equity ratio (including short-term debt) improved slightly to 0.51 from 0.52.

6. Data Gaps

• Quarterly year-over-year comparisons for 2026 quarters (only Q2 2026 vs Q2 2025 available; Q1 2025, Q3 2024, Q4 2024 not provided).
• Free cash flow metric not directly reported; would require capital expenditures breakdown by segment for each year.
• CNA's combined ratio and underlying combined ratio trends prior to 2024 not provided in the filings.
• Boardwalk Pipelines' distributable cash flow and coverage ratios not disclosed in the provided excerpts.
• Parent company cash and investment income volatility details beyond the two-year comparison.
• Impact of the One Big Beautiful Bill Act (OBBBA) on future tax expense not quantified.